The À¶Ý®ÊÓƵ À¶Ý®ÊÓƵ (BRC) harnesses the scientific power of , the only UK University devoted wholly to science, engineering, business and medicine, and the UK’s largest group of research-intensive hospitals . The aim of this partnership is to rapidly translate scientific discoveries into the clinic, through our five hospitals which serve an ethnically diverse population of 2.3 million people in North-West London. Our activities are focused on developing new devices, diagnostics, new therapies and in analysing and integrating health data.
The BRC supports the infrastructure to promote and facilitate the flow of research from laboratory bench to patient bedside as effectively and efficiently as possible. It provides an environment in which scientific endeavour can thrive, attracts talented investigators from across the globe, and produces world-class outputs, contributing to the UK’s international competitiveness as a major component of our knowledge economy.
The BRC drives innovation in the prevention, diagnosis and treatment of ill-health by funding and supporting people- or patient-focused early translational research. Our work is split into fourteen Research Themes, each of which represents a substantial portfolio of internationally excellent experimental medicine research, in areas of unmet clinical need.
The 14 Themes are linked by four common threads:
- Early diagnosis – developing new tests and improving current testing to speed up diagnosis and allow earlier
treatment - Precision medicine – tailoring treatment to a patient’s specific needs to improve outcomes
- Digital health – using computer technology to provide clinicians with more accurate information for better treatment
and allow patients to manage their health - Convergence science – bringing different scientific fields together to provide new perspectives and solve complex
health research challenges
The BRC also invests in cutting-edge technology platforms, as well as other core facilities, NHS support units, and training of the next generation of clinical academics.
The BRC is the engine of our , creating a vibrant pipeline of high-quality early translational research – new devices, diagnostics, therapeutics and data-driven healthcare research.
Key Individuals
-
Dr Nichola Cooper
Theme Lead, Immunology -
Erik Mayer
Director iCARE & Clinical Reader, Department of Surgery & Cancer -
Professor Iain McNeish
Professor of Oncology and Head of Division of Cancer - Co-Theme Lead -
Professor Jonathan Weber
Dean, Faculty of Medicine -
Professor Mark Thursz
À¶Ý®ÊÓƵ Imperial BRC Director -
Professor Waljit Dhillo
Theme Lead & À¶Ý®ÊÓƵ Imperial BRC Training Lead -
Dr Bob Klaber
Director of strategy, research and innovation -
Dr Lucia Li
À¶Ý®ÊÓƵ Clinical Lecturer (Neurology) -
Dr Stephen Brett
Reader in Critical Care -
Mr Christopher Peters
-
Prof Christina Fotopoulou
Consultant gynaecological oncologist -
Prof Mary Wells
Professor and Lead for Nursing and Midwifery - Theme Committee Member -
Professor Anthony Gordon
Chair in Anaesthesia and Critical Care -
Professor Elaine Holmes
-
Professor Eric Aboagye
Professor -
Professor Jane Apperley
Chair of the Department of Haematology -
Professor Jorge Ferrer
Chair in Medicine and Genetics -
Professor Marina Botto
Professor of Rheumatology -
Professor Martin Wilkins
Vice Dean (Research) Faculty of Medicine -
Professor Paul Elliott
Theme Lead, Informatics & Biobanking -
Professor Paul Matthews
Edmond and Lily Safra Chair, Head of Department -
Professor Peter Openshaw
Professor of Experimental Medicine -
Professor Sian Harding
Emeritus Professor of Cardiac Pharmacology -
Professor Sir Steve Bloom
Professor of Medicine -
Professor The Lord Ara Darzi
Paul Hamlyn Chair of Surgery
